Abbott (ABT) Tops Q4 EPS by 11c, Revenues Beat
Get Alerts ABT Hot Sheet
Price: $108.33 -0.42%
Revenue Growth %: +14.2%
Financial Fact:
Other (income) expense, net: 972M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +14.2%
Financial Fact:
Other (income) expense, net: 972M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q4 EPS of $1.03, $0.11 better than the analyst estimate of $0.92. Revenue for the quarter came in at $10.1 billion versus the consensus estimate of $9.62 billion.
GUIDANCE:
Abbott sees FY2023 EPS of $4.30-$4.50, versus the consensus of $4.40.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance
- Lynx Equity sees Micron and SanDisk breakout as volatility normalizes
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share